WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

BENEFIT OVER RISK OF USING CHLOROQUINE AND HYDROXYCHLOROQUINE IN COVID – 19 PATIENTS

Purushottam Ghosh*

ABSTRACT

The increasing mortality rate across the world lead the medical professionals to find alternatives to curve down the deceased rate and the spread the novel coronavirus pandemic however the potential vaccination for the said virus might need some more time to develop. Recently many studies were conducted on the benefit of chloroquine and hydroxychloroquine in the prevention and management of COVID-19. Moreover the evidence of safety profile of these drugs in COVID-19 patients is very weak due to lack of clinical trials. However, most studies did not address the clinically associated side effects and toxicity associated with both the drugs. This article provides a brief note on its potential side effects that might arise during the medical therapy of the COVID-19 patients.

Keywords: coronavirus, chloroquine, hydroxychloroquine, COVID-19.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More